» Articles » PMID: 36143365

Cross-Sectional Comparative Study on Central Sensitization-Psychosocial Associated Comorbidities and Psychological Characteristics in Breast Cancer Survivors with Nociceptive Pain and Pain with Neuropathic Features and Without Pain

Abstract

The frequency of a high Central Sensitization Inventory (CSI) total score and the prevalence of pain have already been established among breast cancer survivors (BCS). However, the psychological factors' influence based on the clinical features of pain is still unknown, as well as BCS characteristics with no pain. Thus, our main aim was to evaluate the presence of a high CSI total score in BCS with pain and compare it with BCS without pain and to evaluate the influence of psychosocial factors. A cross-sectional comparative study was designed to compare BCS with nociceptive pain ( = 19), pain with neuropathic features ( = 19) or no pain ( = 19), classified by the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS). CSI, pain catastrophizing, fear of movement, anxiety and depression symptoms were analyzed and compared among the three groups. The CSI total score was higher in both BCS pain groups compared to BCS without pain, but there were no statistical differences between the pain groups. The same observation was made when comparing pain catastrophizing. The neuropathic feature group showed greater levels of fear of movement, anxiety and depression compared to the no pain group. Thus, CS-psychosocial associated comorbidities and pain-catastrophizing thoughts were more prevalent among BCS with pain, regardless of the clinical features of pain. BCS with neuropathic pain features showed greater psychological disturbances.

Citing Articles

Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study.

Mibu A, Manfuku M, Nishigami T, Yamashita H, Imai R, Kanamori H Breast Care (Basel). 2024; 19(4):207-214.

PMID: 39185132 PMC: 11341075. DOI: 10.1159/000539867.


The Association of Central Sensitisation with Depression, Anxiety, and Somatic Symptoms: A Cross-Sectional Study of a Mental Health Outpatient Clinic in Japan.

Takeuchi T, Hashimoto K, Koyama A, Asakura K, Hashizume M Life (Basel). 2024; 14(5).

PMID: 38792633 PMC: 11122528. DOI: 10.3390/life14050612.


Central Sensitization in Cancer Survivors and Its Clinical Implications: State of the Art.

Nishigami T, Manfuku M, Lahousse A J Clin Med. 2023; 12(14).

PMID: 37510721 PMC: 10380903. DOI: 10.3390/jcm12144606.


Global research trends of acupuncture therapy on cancer pain: A bibliometric and visualized study.

Li C, Zhao C, Zhao J, Wang M, Luo F, Zhou J Front Oncol. 2023; 13:1077961.

PMID: 36950556 PMC: 10026736. DOI: 10.3389/fonc.2023.1077961.

References
1.
Matesanz-Garcia L, Cuenca-Martinez F, Simon A, Cecilia D, Goicoechea-Garcia C, Fernandez-Carnero J . Signs Indicative of Central Sensitization Are Present but Not Associated with the Central Sensitization Inventory in Patients with Focal Nerve Injury. J Clin Med. 2022; 11(4). PMC: 8876893. DOI: 10.3390/jcm11041075. View

2.
Osman A, Barrios F, Gutierrez P, Kopper B, Merrifield T, Grittmann L . The Pain Catastrophizing Scale: further psychometric evaluation with adult samples. J Behav Med. 2000; 23(4):351-65. DOI: 10.1023/a:1005548801037. View

3.
Mayer T, Neblett R, Cohen H, Howard K, Choi Y, Williams M . The development and psychometric validation of the central sensitization inventory. Pain Pract. 2011; 12(4):276-85. PMC: 3248986. DOI: 10.1111/j.1533-2500.2011.00493.x. View

4.
Schreiber K, Kehlet H, Belfer I, Edwards R . Predicting, preventing and managing persistent pain after breast cancer surgery: the importance of psychosocial factors. Pain Manag. 2014; 4(6):445-59. DOI: 10.2217/pmt.14.33. View

5.
Wang K, Yee C, Tam S, Drost L, Chan S, Zaki P . Prevalence of pain in patients with breast cancer post-treatment: A systematic review. Breast. 2018; 42:113-127. DOI: 10.1016/j.breast.2018.08.105. View